Upon ADI-PEG 20 treatment, leiomyosarcoma and melanoma cells shunted glucose-derived carbons into the serine biosynthesis pathway, leading to susceptibility to anti-folates and glutaminase inhibition [54]. This evidence concerns the gene GLS and melanoma.